The launch event of Sovaaka, Dr. Lal PathLabs Limited's new-age Diagnostic Experience Centre in Gurugram, was graced by the Hon’ble Chief Minister of Haryana, Shri Nayab Singh Saini. Built on the philosophy of “Science Behind Wellness,” Sovaaka introduces a new standard in preventive and lifestyle healthcare. The centre brings together precision diagnostics, cutting-edge technology, and medical expertise to help individuals take proactive control of their health.

Karen, an aspiring Paralympic archer living with multiple sclerosis (MS) for nearly three decades, consulted Dr Susmitha C, a specialist in neurological and autoimmune conditions at Apollo AyurVAID Hospitals, and enrolled in a rigorous Precision Ayurveda programme. Karen’s treatment plan combined classical Panchakarma therapies, targeted Ayurveda medication, a therapeutic diet and focused neuro-rehabilitation formed the cornerstone of her care.

Eli Lilly and Company announced plans to invest more than $1 billion over the next several years into new contract manufacturing in India, expanding patients’ access to innovative medicines around the world. In addition, Lilly will establish a new Manufacturing & Quality presence in Hyderabad. This new hub will offer advanced technical capabilities and oversight for Lilly’s contract manufacturing network across India. Recruitment will begin immediately.